Fulcrum Therapeutics (FULC) - Net earnings per share (EPS TTM)

Symbol and logo of brand fulcrumtx.com (FULC)

Fulcrum Therapeutics develops innovative small molecules to correct genetic defects. Current earnings per share over the last 12 months demonstrate phases of capital consolidation, with this metric standing at -1.03. The company diversifies risks by developing treatments for blood and muscle pathologies. The strategy is based on independent clinical trials without engaging in mergers and acquisitions.

FULC (fulcrumtx.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Fulcrum Tx (FULC)

- share price and expert price forecast:
General company analysis:fulcrumtx.com (FULC)
Mass-produced product of Fulcrum Therapeutics Inc

This indicator measures capital generation efficiency by dividing total annual net income by the total number of shares to determine the actual return per share. By analyzing the company's net income per share over 12 months, an investor assesses the financial stability of Fulcrum Therapeutics (FULC) against the development costs of losmapimod and its strategic partnership with Sanofi.

Competitors of Fulcrum Therapeutics (FULC)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)